Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450307
Status:
COMPLETED
Last Update Posted:
2013-10-16
First Post:
2007-03-20
Brief Title:
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk Refractory or Relapsed Neuroblastoma
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center